Immunotherapeutic role of cabazitaxel treatment in the activation of TLR3 signalling in metastatic castration-resistant prostate cancer in vitro

dc.date.accessioned	2023-03-06T07:32:03Z
dc.date.available	2023-03-06T07:32:03Z
dc.date.issued	2022
dc.identifier.citation	Mol Biol Rep. 2022 Feb;49(2):1261-1271. doi: 10.1007/s11033-021-06953-2. Epub 2021 Nov 26.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100144
dc.relation.isversionof	10.1007/s11033-021-06953-2
dc.relation.isversionof	10.1007/s11033-021-06953-2
dc.title	Immunotherapeutic role of cabazitaxel treatment in the activation of TLR3 signalling in metastatic castration-resistant prostate cancer in vitro
dc.relation.journal	Mol Biol Rep
dc.identifier.doi	10.1007/s11033-021-06953-2
dc.contributor.author	Deveci Ozkan A
dc.contributor.author	Deveci Ozkan A
dc.contributor.author	Guney Eskiler G
dc.contributor.author	Kaleli S
dc.contributor.author	Sahin E.